Global health ipo

The initial public offer (IPO) of Dr Naresh Trehan-led Global Health Limited will open today. Trehan, a renowned cardiovascular and cardiothoracic surgeon, is also the promoter of the company. The company operates and manages hospitals under the Medanta brand. The firm has raised Rs 662 crore from anchor investors. Global Health has decided to allocate 1.97 crore equity shares at Rs 336 apiece, aggregating the transaction size to about  Rs 662 crore. The anchor investors include--Government of Singapore, Nomura, Axis Mutual Fund (MF), HDFC MF, Aditya Birla Sun Life MF, SBI MF, ICICI Prudential MF, Kotak MF, Max Life Insurance Company and SBI Life Insurance Company. The IPO of the multi-speciality tertiary care provider will end on November 7. The company will offer its shares in a price band of Rs 319 to Rs 336.  At the upper end of the price band, the share sale is expected to fetch Rs 2,206 crore. The lot size of Global Health IPO is 44 shares for which one will have to spend Rs 14,784. A retail individual investor can submit bids for up to 13 lots or 572 shares by spending Rs 1,92,192. The grey market premium (GMP) of Global Health IPO stands at Rs 15 today, according to IPO Watch. This implies that the stock is likely to be listed at Rs 351. The firm will carry out allotment of shares on November 11, 2022. The shares are likely to be listed on BSE and NSE on November 16, 2022. KFin Technologies Limited is registrar to the IPO. The IPO consists of a fresh issue of equ...

Check Global Health IPO allotment status online by clicking the button below. If you have difficulties finding the Global Health Limited IPO allotment status, please visit the website of the IPO registrar. Note: Registrar of the Global Health IPO is responsible for IPO allotment. Please contact the registrar with any quires related to stock allocation or refund related problems. To understand the allocation of shares for Global Health Limited IPO, check the 'basis of allotment' document. Below are the steps to check Global Health IPO allotment status online: • Visit the • Click on the green Global Health IPO Allotment Status. • Enter either PAN number, Application Number or DP Client ID of the demat account to check the Global Health IPO allotment status. • Click Search. Note: The disabled button shows that the allotment is not yet available online. The allotment result looks like as below: • PAN No.: AHMLK1898J • Application No.: RL041213805307 • Name: Mr. Rajveer Singh • Shares Applied: 40 • Shares Allotted: 40 If Global Health IPO oversubscribed in the retail category, the Global Health IPO shares will be distributed on a proportionate basis to Retail Individual Investors (RII). Each retail investor will get a minimum of 1 lot subject to the availability of shares in the retail portion. If enough shares are not available, a lottery is drawn to choose the investors.

Review By Dilip Davda on Oct 29, 2022 •GHL is a world-renowned multi-speciality healthcare centre operating under the "Medanta" brand. •It has reported growth in its working except for FY21, the pandemic year. •The issue is attractively priced compared to its listed peers. •Investors may consider investing in this issue with medium to long-term perspectives. ABOUT COMPANY: Global Health Ltd. (GHL) is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India, as of and for the financial year ended March 31, 2022, with key specialities of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology, according to CRISIL Report. Under the "Medanta" brand, it has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow, and Patna) and one hospital (Noida), which is under construction. As of June 30, 2022, it provides healthcare services in over 30 medical specialities and engages over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., its operational hospitals have 2,467 installed beds. GHL's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021, and 2022, and was the only Indian private h...

Premium Global Health IPO opens today: All you need to know Medanta operator Global Health IPO GMP today, November 03, 2022: The Rs 2,206 crore initial public offering (IPO) of Global Health, which operates hospitals under the Medanta brand, is available from November 3-7, 2022. It has a price band of Rs 319-336 per share. Global Health IPO GMP, Check Price Band, Review: The initial public offering (IPO) of Global Health, which operates hospitals under the Medanta brand, opened for subscription on Thursday, November 3, 2022. It opened for public subscription at 10 am and was subscribed around 9 per cent by 2:45 pm on the first day of bidding. It received total bids for 43,59,960 shares across both the stock exchanges against 4,67,42,397 shares on offer, data from National Stock Exchange (NSE) showed. The Rs 2,206 crore Global Health Rs 319-336 per share. The IPO comprises of a fresh issue of equity shares aggregating to Rs 500 crore and an offer for sale (OFS) of up to 50,761,000 equity shares. Anant Investments (an affiliate of Carlyle Group) and Sunil Sachdeva (jointly with Suman Sachdeva) will be offloading shares through the OFS. The net proceeds from the fresh issue will be used for repayment/prepayment of borrowings of its subsidiaries – GHPPL and MHPL and for general corporate purposes, according to the information given in the Half of the issue size has been reserved for qualified institutional buyers (QIBs), 15 per cent for non-institutional investors and the rema...

Global Health Ltd. One of the largest private multi-speciality tertiary care providers operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. It operated under brand name "Medanta". Global Health informs about analyst meet 2 Jun, 5:08PM Global Health - Quaterly Results 27 May, 6:13PM Global Health - Quaterly Results 27 May, 6:13PM Global Health informs about closure of trading window 31 Mar, 4:53PM Global Health submits analyst meet intimation 25 Mar, 12:28PM Global Health informs about conference call transcript 20 Feb, 5:18PM Global Health submits monitoring agency report 14 Feb, 2:29PM Global Health - Quaterly Results 13 Feb, 6:31PM Global Health informs about certificate 5 Jan, 5:13PM Global Health informs about press release 28 Dec, 3:03PM Global Health informs about outcome of board meeting 22 Dec, 3:21PM Global Health informs about investors meet 12 Dec, 9:39AM Global Health informs about investor meeting 5 Dec, 4:51PM Global Health informs about analyst meet 29 Nov, 12:43PM Global Health informs about investors meet 28 Nov, 1:13PM Global Health informs about analyst meet intimation 21 Nov, 5:05PM Global Health coming with an IPO to raise upto Rs 2232 crore 1 Nov, 1:05PM Global Health files IPO papers with SEBI 5 Oct, 1:28PM Subscription Details The details about the Global Health LtdIPO is as: • Th...

Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. It has a network of four hospitals in Gurugram, Indore, Ranchi, Patna and Lucknow. As of June 30, 2022, the company provided healthcare services in over 30 medical specialties and engaged over 1,300 doctors led by experienced department heads. The operational hospitals have 2,467 installed beds. The majority of the brokerages remain positive on the issue and suggest subscribing to it, citing decent valuations, growth prospects and robust business model. However, higher expenses are a major risk for the company. “In FY22, Global Health had the second-largest operating profit margin against its listed peers. Global Health also had the second-highest average revenue per occupied bed in FY22,” said KR Choksey Research in its IPO note. "An increase in total bed capacity and an improvement in occupancy rates across hospitals can further aid margins. Debt reduction at the subsidiary level will lead to better profitability ratios," it added with a 'subscribe' rating for the issue. For the year 2021-22, the company reported a profit after tax (PAT) of Rs 196.2 crore with a revenue of Rs Rs 2,205.82 crore. Its PAT stood at Rs 58.71 crore with total revenue at Rs 626.54 crore for the period ended June 30, 2022. “Over FY19-22, Medanta’s operational and financial performance has been strong and weathered the challenge of the pandemic. Reduction in emplo...

Global Health IPO review: Initial public offering (IPO) of Global Health Limited, which operates hospitals under the Medanta brand, is now open for subscription. According to an exchange filing, the company has decided to allocate 1.97 crore equity shares at Rs 336 apiece, aggregating the transaction size to about Rs 662 crore. Global Health IPO review by Anil Singhvi "There are chances of some listing gains but considering the sentiments of Indian share markets and uncertainties in the global market. This is why one should focus on long-term gains. I usually suggest for short-term listing gains only when I see a clear upside of 20-25 per cent," Singhvi said. ग्लोबल हेल्थ का IPO, प्राइस बैंड ₹319-336/शेयर ग्लोबल हेल्थ कंपनी में क्या पॉजिटिव, कहां है जोखिम? इश्यू में पैसा लगाएं या नहीं? जानिए — Zee Business (@ZeeBusiness) Singhvi said that Global Health, backed by private equity investors such as Carlyle Group and Temasek, is known for providing the best health services. It operates a network of five hospitals under the 'Medanta' brand in Gurugram, Indore, Ranchi, Lucknow and Patna. In addition, one hospital is under construction in Noida. "Also, the financials of the company is very strong and the cash flow is positive. After this IPO, the company will be debt free. This is one of the sectors that has very strong growth prospects in the future. However, there are some negatives as well. One of them is the attrition rate of doctors is a bit high. It is 32 per cent for docto...